Wednesday, May 25, 2016 5:40:00 AM PDT | VentureDeal
San Mateo, California -- Software technology company Apixio has landed $19.3 million in its fourth round of institutional venture capital investment.
Apixio says that it is "a cognitive computing company whose unique platform powers a risk adjustment tool called HCC Profiler." HCC Profiler analyzes millions of patient charts to enable healthcare payers to "identify codes, find documentation gaps and validate submitted codes" more quickly and accurately than previously. SSM Partners (Casey West) led the round, which also included previous investors First Analysis (Frank Sparacino) and Bain Capital Ventures (Jared Kesselheim). The company said it would use the funding to advance its platform and scale its operations. Apixio CEO Darren Schulte was originally its Chief Medical Officer starting in October 2011 and is a member of the Board of Directors.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
